Science Explorer Back to mapMap
Discussion
Researcher · Prisma Health · United States

Jeffrey Kent Giguere

Jeffrey Kent Giguere publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Cancer survivorship and care, Cancer-related cognitive impairment studies and Cancer Treatment and Pharmacology.

OpenAlex
World rank
#634,496
of 7,710,434 ranked researchers
Rank in United States
#216,596
of 1,627,098
Works
90
Citations
8.4k
Citations per work
93.8
h-index
26
i10-index 45Top 15% in Oncology
Jeffrey Kent Giguere

What does Jeffrey Kent Giguere research?

Jeffrey Kent Giguere's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (8%).

Health Sciences: 54 works · 60.4% of their workMedicine: 54 works · 60.4% of their workOncology: 31 works · 34.0% of their workPulmonary and Respiratory Medicine: 14 works · 16.0% of their workSurgery: 4 works · 4.0% of their workPathology and Forensic Medicine: 3 works · 3.6% of their workGeriatrics and Gerontology: 3 works · 2.8% of their workEverything else: 28 works · 31.2% of their workLife Sciences: 8 works · 8.4% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 8.4% of their workMolecular Biology: 8 works · 8.4% of their workTHEIR WORKJeffrey KentGiguere90works
Life Sciences8%Health Sciences60%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5460.4%
  2. Everything else2831.2%
    1. Biochemistry, Genetics and Molecular Biology88.4%
  1. 1Oncology34% of their works
  2. 2Pulmonary and Respiratory Medicine16% of their works
  3. 3Molecular Biology8% of their works
  4. 4Surgery4% of their works
  5. 5Pathology and Forensic Medicine4% of their works
  6. 6Geriatrics and Gerontology3% of their works

Research topics

Which keywords describe Jeffrey Kent Giguere's research?

The keywords of their largest research topics: Quality of Life, Chemotherapy, Cancer Survivorship, Patient-Reported Outcomes, Breast Cancer, Cognitive Function, Chemotherapy-Induced Peripheral Neuropathy and Taxanes.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Quality of Life342 topics
  2. Chemotherapy313 topics
  3. Cancer Survivorship211 topic
  4. Patient-Reported Outcomes211 topic
  5. Breast Cancer151 topic
  6. Cognitive Function151 topic
  7. Chemotherapy-Induced Peripheral Neuropathy131 topic
  8. Taxanes131 topic
  9. Cetuximab91 topic
  10. EGFR Mutations91 topic
  11. KRAS Mutations91 topic
  12. Targeted Therapy91 topic
  13. DNA71 topic
  14. Frailty71 topic
  15. Geriatric Assessment71 topic
  16. Immune Checkpoint Blockade71 topic
  17. PD-1 and PD-L171 topic
  18. Topoisomerases71 topic

Where does Jeffrey Kent Giguere work?

Jeffrey Kent Giguere's main affiliation in the publication record is Prisma Health, United States.

How many publications and citations does Jeffrey Kent Giguere have?

OpenAlex counts 90 works and 8,440 citations for Jeffrey Kent Giguere, an h-index of 26, ranking #634,496 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jeffrey Kent Giguere. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.